Ledger.Open graph →
SEC Form D · filed July 20, 2018

Stemgenics, Inc

Offering
$20.0M
Sold
$445K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Aaron Skonnard · Farmington, UTExec · DirectorDavid Hite · Los Angeles, CAExec · DirectorGeneration Growth Capital Partners III, LLC · Milwaukee, WIExec · DirectorNate Walkingshaw · Farmington, UTExec · DirectorRyan Hinkle · Farmington, UTExec · DirectorMarcus Segal · Los Angeles, CAExec · DirectorAnush S. Oganesian · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗